Myeloid disorders after autoimmune disease
Boddu P, Zeidan AM. Myeloid disorders after autoimmune disease. Best Practice & Research Clinical Haematology 2019, 32: 74-88. PMID: 30927978, PMCID: PMC6541412, DOI: 10.1016/j.beha.2019.02.002.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAutoimmune diseasesMyeloid neoplasmsTherapy exposureAnti-tumor necrosis factor-alpha inhibitorsNecrosis factor-alpha inhibitorsPlausible biologic mechanismsAnti-rheumatic drugsChronic immune stimulationSystemic lupus erythematosusBone marrow infiltrationMN developmentInflammatory bowel disordersAcute myeloid leukemiaAD typeDuration of exposureMN pathogenesisParaclinical featuresBowel disordersLupus erythematosusMarrow infiltrationLymphoproliferative disordersRheumatoid arthritisMultiple sclerosisMyelodysplastic syndromeExcess risk